Orthopedic robotics company Corin has earned FDA clearance for the ApolloHipX, a total replacement application designed for the Corin Apollo platform.
The ApolloHipX is the first and only hip replacement technology to integrate 3D preoperative planning with intraoperative fluoroscopy, which allows surgeons to implement personalized patient plans with greater precision and efficiency, according to a Jan. 14 news release.
ApolloHipX uses 3D images to provide a more accurate assessment of a component position from a single image, according to the company. This will result in fewer intraoperative images and aims to optimize surgical efficiency while minimizing radiation exposure within the operating room.
The application is also compatible with Corin’s full portfolio of hip implants, including the new Icona, a triple-taper, fully coated, cementless femoral stem.